Medical Condition News

RSS

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

AstraZeneca today announced that the orphan drug vandetanib is now available to U.S. patients for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.

25 Apr 2011

Enrollment commences in Gore Early TIPS study for ascites at Indiana University Hospital

W. L. Gore & Associates today reported the first patient enrolled in the Gore Early TIPS for Ascites Study. The patient was treated at Indiana University Hospital in Indianapolis, Ind.

25 Apr 2011

Cambridge Heart releases new MTWA software

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced the release of its redesigned Microvolt T-Wave Alternans software for its HearTwave II and CH2000 platforms.

25 Apr 2011

Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack

Bayer HealthCare Pharmaceuticals, Inc. is aware of two studies published today in The British Medical Journal, ONLINE FIRST.

25 Apr 2011

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.

25 Apr 2011

STAA receives CE Mark approval for Visian Implantable Collamer Lens V4 design

STAAR Surgical Company, the leading developer, manufacturer and marketer of minimally invasive ophthalmic lenses for refractive surgery, today announced CE Mark approval for its Visian Implantable Collamer Lens V4c design.

25 Apr 2011

NCM, National Park Foundation partner to combat childhood obesity

The National Children's Museum announces that it has partnered with the National Park Foundation, the official charity of America's national parks, to support the 2011 White House Easter Egg Roll.

25 Apr 2011

XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

XenoPort, Inc. announced today that it had reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for a pivotal Phase 3 clinical trial of arbaclofen placarbil, previously known as XP19986, as a potential treatment of spasticity in multiple sclerosis patients.

25 Apr 2011

VDF seeks nominations for PAD and venous disease research awards

The Vascular Disease Foundation is seeking nominations for research awards through its Peripheral Arterial Disease and Venous Disease Coalitions. Research awards recognize the important research relevant to the understanding and/or treatment of arterial and venous diseases.

25 Apr 2011

Individuals on SSRIs still exhibit depressive symptoms

Even people who show a clear treatment response with antidepressant medications continue to experience symptoms like insomnia, sadness and decreased concentration, researchers at UT Southwestern Medical Center have found after analyzing data from the largest study on the treatment of depression.

25 Apr 2011

New research provides insight into mechanism behind cardiac development

During embryonic development, cells migrate to their eventual location in the adult body plan and begin to differentiate into specific cell types. Thanks to new research at the University of Pennsylvania, there is new insight into how these processes regulate tissues formation in the heart.

25 Apr 2011

New book on aging

Aging is a natural part of life. From the minute we are born we are heading in one certain direction: towards death. That said, it is possible to arrive at that ultimate destination graceful and vital to our last days rather than chronically ill suffering from one or many debilitating illnesses.

25 Apr 2011

Researchers to develop Alzheimer's diagnostic test based on spinal fluid biomarkers

Researchers at the University of Kentucky are working on a potential diagnostic test for Alzheimer's disease, based on biomarkers in cerebrospinal fluid.

25 Apr 2011

New findings can lead to better understanding of neurological development, cancer metastasis

By shedding new light on how cells migrate in the developing brain, researchers at Fred Hutchinson Cancer Research Center also may have found a new mechanism by which other types of cells, including cancer cells, travel within the body.

25 Apr 2011

LoJack announces availability of SafetyNet service in Miami-Dade County

LoJack SafetyNet, Inc., a wholly owned subsidiary of LoJack Corporation, today announced that its SafetyNet service is now available in Miami-Dade County.

25 Apr 2011

Pfizer comments on abstract concerning ORAL Sync tofacitinib Phase 3 study in RA

Pfizer Inc. commented on an abstract concerning the ORAL Sync Phase 3 study of tofacitinib in patients with rheumatoid arthritis which has been posted for the European League Against Rheumatism conference.

25 Apr 2011

Cornell University professor comments on interventions identified by new Alzheimer's guidelines

Paul Eshelman, professor of Design and Environmental Analysis at Cornell University, comments on intervention strategies for earlier stages of Alzheimer's Disease identified by the Alzheimer's Association's new guidelines for diagnosis.

25 Apr 2011

Epic Imaging receives 100% Mammography Quality Standards Act score

Epic Imaging recently received a 100 percent score on its yearly American College of Radiology Mammography Quality Standards Act inspection.

25 Apr 2011

Eisai receives FDA Complete Response Letter for Aricept Patch NDA

Eisai announced today that the United States Food and Drug Administration issued a Complete Response Letter to Teikoku Pharma USA, Inc., regarding the New Drug Application of the Aricept® Patch.

25 Apr 2011

Noninvasive Masimo carboxyhemoglobin can effectively screen ED patients for CO poisoning

Masimo announced today that a new study published in this month's issue of the peer-reviewed journal, Annals of Emergency Medicine, demonstrates that noninvasive Masimo carboxyhemoglobin measurements provide an "effective means for screening at-risk populations for CO poisoning" with "acceptable bias and precision" compared to invasive blood gas analysis.

25 Apr 2011

Medical Condition News

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

Enrollment commences in Gore Early TIPS study for ascites at Indiana University Hospital

Cambridge Heart releases new MTWA software

Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

STAA receives CE Mark approval for Visian Implantable Collamer Lens V4 design

NCM, National Park Foundation partner to combat childhood obesity

XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

VDF seeks nominations for PAD and venous disease research awards

Individuals on SSRIs still exhibit depressive symptoms

New research provides insight into mechanism behind cardiac development

New book on aging

Researchers to develop Alzheimer's diagnostic test based on spinal fluid biomarkers

New findings can lead to better understanding of neurological development, cancer metastasis

LoJack announces availability of SafetyNet service in Miami-Dade County

Pfizer comments on abstract concerning ORAL Sync tofacitinib Phase 3 study in RA

Cornell University professor comments on interventions identified by new Alzheimer's guidelines

Epic Imaging receives 100% Mammography Quality Standards Act score

Eisai receives FDA Complete Response Letter for Aricept Patch NDA

Noninvasive Masimo carboxyhemoglobin can effectively screen ED patients for CO poisoning

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News